Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...
The company revealed net income rose 57% for the final quarter of 2024, while revenue increased 37% to almost $27 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback